[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Neumora Therapeutics faces scrutiny over M4 specificity concerns and a declining stock price, despite some positive mentions of potential price increases and recent insider buying.
Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases.
Neumora Therapeutics, Inc. Common Stock uses the ticker $NMRA for trading. Listed in the Stocks category.
Price 24-Hour Time-Series Raw Data
The stock price is declining due to negative analyst ratings and market downturn, with social media activity around options volume and insider transactions indicating speculative interest rather than sustained recovery.
24-Hour: -XXXX% 7-Day: -XXX% 30-Day: -XXXXX%
1-Year High: $XXXXX on 2024-12-26
1-Year Low: $XXXXX on 2025-05-14
AltRank 24-Hour Time-Series Raw Data
Neumora Therapeutics, Inc. Common Stock (NMRA) is currently AltRank #1,707 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +693
X Month: XXXXX +360
X Months: XXXXX -XXX
X Year: XXXXX +927
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-02-23
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -XX
X Month: XX -XX
X Months: XX -XX
X Year: XX -XX
1-Year High: XX on 2025-07-09
1-Year Low: X on 2025-04-04
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -X%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +73%
1-Year High: XXXXXXX on 2025-01-02
1-Year Low: X on 2025-10-11
Engagements by network (24h): X: XXX
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XXXX%
X Months: XXXXX +27%
X Year: XXXXX +193%
1-Year High: XXX on 2025-01-02
1-Year Low: X on 2025-10-11
Mentions by network (24h): X: XX
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Neumora Therapeutics, Inc. Common Stock (NMRA) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXX +4.70%
X Months: XXXXX +100%
X Year: XXXXX +142%
1-Year High: XXX on 2025-01-06
1-Year Low: X on 2025-10-11
The most influential creators that mention Neumora Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @StockTickerZone | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -XX%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2025-04-06
1-Year Low: X% on 2025-12-09
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
X Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
X Month: XXXXXXX% +0.0002700000000000003%
X Months: XXXXXXX% +0.00347%
X Year: XXXXXXX% -XXXXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-10-11
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
X Week: $XXXXXXXXXXX -$9.60%
X Month: $XXXXXXXXXXX -$23%
X Months: $XXXXXXXXXXX +$158%
X Year: $XXXXXXXXXXX -$79%
1-Year High: $XXXXXXXXXXXXX on 2024-12-26
1-Year Low: $XXXXXXXXXX on 2025-05-14
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$NMRA $NOK β π Guys Don't miss the next move in a few hours πΈβ‘"
X Link @Trade_Pro04 2025-12-11T20:57Z XX followers, XX engagements
"$FTEL $COOT $NMRA $ORIS $JBSS π Opportunities abound in the US stock market but many people consistently buy at the peak and sell at the bottom. If you want to capitalize on market trends welcome to join my US stock group"
X Link @ccentrifug64489 2025-12-10T17:10Z XX followers, XX engagements
"The R&D pipeline for depression therapies faced a demoralizing 2025 as five high-profile candidates including KOR antagonists by Johnson & Johnson and Neumora Therapeutics flunked late-stage clinical trials underscoring the persistent challenges of CNS drug development"
X Link @biospace 2025-12-08T21:03Z 25.5K followers, XXX engagements
"Five explosive catalysts are shaping the $CVKD story and why some investors are watching it asap $LASE $IEP $NMRA $RXRX $DKNG $SPY $RUM $AVXL $AISP $TRAW $TSM $SPY $HOLO $FUBO $QQQ $DJT $RGTI $AMD $AMC $AAPL $BIDU $CEG $BABA $SNAP $TSLA $WBA $IOVA"
X Link @sheila_wests 2025-12-04T11:45Z XX followers, XXX engagements